Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PepGen Inc. | Chief Medical Officer | Common Stock | 0 | $0 | $18.06 | Jul 25, 2024 | Direct |
PepGen Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 50K | Jul 25, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PEPG | PepGen Inc. | Jul 24, 2024 | 6 | -$61K | 4 | Jul 26, 2024 | Chief Medical Officer |
PEPG | PepGen Inc. | Jul 18, 2024 | 3 | -$101K | 4 | Jul 19, 2024 | Chief Medical Officer |
PEPG | PepGen Inc. | Jul 12, 2024 | 6 | -$71.8K | 4 | Jul 16, 2024 | Chief Medical Officer |
PEPG | PepGen Inc. | Jul 1, 2024 | 6 | -$7.12K | 4 | Jul 3, 2024 | Chief Medical Officer |
PEPG | PepGen Inc. | Jun 24, 2024 | 3 | -$73.9K | 4 | Jun 26, 2024 | Chief Medical Officer |
PEPG | PepGen Inc. | Jun 11, 2024 | 6 | -$12.4K | 4 | Jun 13, 2024 | Chief Medical Officer |
PEPG | PepGen Inc. | Jun 5, 2024 | 6 | -$68.1K | 4 | Jun 7, 2024 | SVP, Clinical Development |
PEPG | PepGen Inc. | Mar 1, 2024 | 1 | $0 | 4 | Mar 1, 2024 | SVP, Clinical Development |
PEPG | PepGen Inc. | Mar 1, 2023 | 2 | $0 | 4 | Mar 2, 2023 | SVP, Clinical Development |
PEPG | PepGen Inc. | Jul 1, 2022 | 1 | $0 | 4 | Aug 31, 2022 | Sr. VP. Clinical Development |
PEPG | PepGen Inc. | May 6, 2022 | 1 | $0 | 4 | May 10, 2022 | Sr. VP. Clinical Development |
PEPG | PepGen Inc. | May 5, 2022 | 0 | $0 | 3 | May 5, 2022 | Sr. VP. Clinical Development Exhibit 24: Power of Attorney |